# Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

> **NCT05898399** · PHASE1,PHASE2 · RECRUITING · sponsor: **Artios Pharma Ltd** · enrollment: 181 (estimated)

## Conditions studied

- Advanced Solid Tumor
- Metastatic Solid Tumor

## Interventions

- **DRUG:** ART6043
- **DRUG:** Olaparib

## Key facts

- **NCT ID:** NCT05898399
- **Lead sponsor:** Artios Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-30
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 181 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05898399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05898399, "Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05898399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*